Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Reborn interim report
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(58)
•••
Comment by SamV21on Dec 30, 2021 12:11pm
84 Views
Post# 34271124

RE:RE:RE:Reborn interim report

RE:RE:RE:Reborn interim report Tilray is working with Teva a 10 billion dollar company on Syqe that can be used in hospital where Tetra mighty medic can not due to combustion that doesn't mix well with oxygen.Intelgenx is a company that Tetra gave undisclosed amounts to pre manufacturing and is in a law suit with Tilray/Aphria over the film medications that Intelgenx makes a 64 million dollar company trading at .415 and only 31,000 shares traded today so far. Tilray will drain it dry put it out of business, then what happens to the money Tetra sunk into Intelgenx making  the same film product that Tilray is gearing up for. Guy is just a general contractor buying himself an over paid job with our money investing in these nothing companies with no planning or budgeting or we wouldn't be in this mess.
Pipeline of nothing to now where , how can you be a leader when you have nothing approved , reports mean nothing and don't make us any money.Like a taxi company saying they are the leader with no fares and no cars on the road. Its all dreams thus far, dreams Guy did no budgeting for before hand or he knew and didn't care , its not his money he is burning.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities